Shanghai - Delayed Quote CNY

TIANTAN BIO (600161.SS)

Compare
20.31
-0.19
(-0.93%)
At close: 3:00:02 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
1,351,188.52
2,393,576.03
1,126,002.19
980,350.20
702,109.60
Operating Cash Flow
877,072.24
2,393,576.03
1,126,002.19
980,350.20
702,109.60
Investing Cash Flow
-571,348.04
-1,246,906.91
-1,870,901.29
-2,184,963.52
-620,467.91
Financing Cash Flow
-587,456.91
-508,083.83
-378,202.35
2,774,371.13
254,165.65
End Cash Position
3,540,564.83
2,832,587.03
2,194,002.07
3,317,151.43
1,747,404.67
Capital Expenditure
-1,081,359.77
-1,077,540.02
-1,354,019.75
-1,131,697.35
-608,905.85
Issuance of Debt
--
--
--
--
400,000.00
Repayment of Debt
--
-366,250.00
-107,500.00
-326,250.00
--
Free Cash Flow
269,828.74
1,316,036.01
-228,017.56
-151,347.16
93,203.76
12/31/2020 - 6/16/1998

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade